Education
Academic Background-
Ph.D. University of Queensland, Australia Pharmacokinetics | Completed: 1987
Publications (56)
Selected Scholarly Contributions
BSA and ABCB1 polymorphism affect the pharmacokinetics of sunitinib and its active metabolite in Asian mRCC patients receiving an attenuated sunitinib dosing regimen.
Dr. Kwon Kwang-il
2016
Quantitative determination of amisulpride in rat plasma by HPLC-MS/MS.
Dr. Kwon Kwang-il
2015
Absolute bioavailability and metabolism of aceclofenac in rats.
Dr. Kwon Kwang-il
2015
Pharmacokinetic modeling and monte carlo simulation of ondansetron following oral administration in dogs.
Dr. Kwon Kwang-il
2015
Development of QTc prolongation model incorporating circadian rhythm using harmonic model.
Dr. Kwon Kwang-il
2015
A novel HPLC-MS/MS method for the simultaneous determination of astemizole and its major metabolite in dog or monkey plasma and application to pharmacokinetics.
Dr. Kwon Kwang-il
2015
Determination of influence of food intake after a single oral dose of mosapride in beagle dogs using nonlinear mixed effect modeling.
Dr. Kwon Kwang-il
2015
A study on the predictive factor and adverse effect model of vincristine by regression model in patients with lymphoma.
Dr. Kwon Kwang-il
2014
Semi-Mechanistic modelling and simulation of inhibition of platelet aggregation by antiplatelet agents.
Dr. Kwon Kwang-il
2014
Bioequivalence comparison of two formulations of Fixed-Dose combination Glimepiride/Metformin (2/500 mg) tablets in healthy volunteers.
Dr. Kwon Kwang-il
2014
Development of a population pharmacokinetic model to describe olmesartan medoxomil/ hydrochlorothiazide (20/12.5 mg) FDC tablet in male healthy South Korean subjects.
Dr. Kwon Kwang-il
2014
Inhibition of cytochrome P450 by ethambutol in human liver microsomes.
Dr. Kwon Kwang-il
2014
Simultaneous determination of 7-O-succinyl macrolactin A and its active major metabolite, macrolactin A in dog plasma using high-performance liquid chromatography with UV detection.
Dr. Kwon Kwang-il
2014
Prandial effect on the systemic exposure of amisulpride.
Dr. Kwon Kwang-il
2014
A simple pharmacokinetic model of alendronate developed using plasma concentration and urine excretion data from healthy men.
Dr. Kwon Kwang-il
2014
Development of a pharmacokinetic/pharmacodynamic/disease progression model in NC/Nga mice for development of novel anti-atopic dermatitis drugs.
Dr. Kwon Kwang-il
2014
Effect of food on the pharmacokinetics of rosuvastatin after administration of a single oral dose in dogs.
Dr. Kwon Kwang-il
2013
Quantitative determination of duloxetine and its metabolite in rat plasma by HPLC-MS/MS.
Dr. Kwon Kwang-il
2013
Effect of food intake on the pharmacokinetics of sarpogrelate and its active metabolite following oral administration to beagle dogs.
Dr. Kwon Kwang-il
2013
Pharmacokinetics of angiotensin II receptor blockers in the dog following a single oral administration.
Dr. Kwon Kwang-il
2013
Pharmacokinetic analysis of doxifluridine and its metabolites, 5-fluorouracil and 5-fluorouridine, after oral administration in beagle dogs.
Dr. Kwon Kwang-il
2013
Population pharmacokinetics of multiple alcohol intake in humans.
Dr. Kwon Kwang-il
2013
Effect of dissolved oxygen in alcoholic beverages and drinking water on alcohol elimination in humans.
Dr. Kwon Kwang-il
2013
Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang.
Dr. Kwon Kwang-il
2013
In vitro and In vivo assessment of cytochrome P450-mediated herb-drug interaction of Ssang-hwa-tang.
Dr. Kwon Kwang-il
2013
Development and validation of a sensitive LC-MS/MS method for the simultaneous quantitation of theophylline and its metabolites in rat plasma.
Dr. Kwon Kwang-il
2012
The coffee diterpene kahweol inhibits metastasis by modulating expressions of MMPs and VEGF via STAT3 inactivation.
Dr. Kwon Kwang-il
2012
Capsaicin induces CYP3A4 expression via pregnane X receptor and CCAAT/enhancer-binding protein β activation.
Dr. Kwon Kwang-il
2012
Quantitative determination of amitriptyline and its metabolite in rat plasma by liquid Chromatography-tandem mass spectrometry.
Dr. Kwon Kwang-il
2012
Physicochemical characterization and toxicity of decursin and their derivatives from Angelica gigas.
Dr. Kwon Kwang-il
2012
Effect of decursinol angelate on the pharmacokinetics of theophylline and its metabolites in rats.
Dr. Kwon Kwang-il
2012
Population PK/PD analysis of metformin using the signal transduction model.
Dr. Kwon Kwang-il
2012
Biopharmaceutical characterization of decursin and their derivatives for drug discovery.
Dr. Kwon Kwang-il
2012
Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate-activated protein kinase in human hepg2 cells and obese mice.
Dr. Kwon Kwang-il
2011
Metformin inhibits P-glycoprotein expression via the NF- κB pathway and CRE transcriptional activity through AMPK activation.
Dr. Kwon Kwang-il
2011
Suppression of EGF-induced tumor cell migration and matrix metalloproteinase-9 expression by capsaicin via the inhibition of EGFR-mediated FAK/Akt, PKC/Raf/ERK, p38 MAPK, and AP-1 signaling.
Dr. Kwon Kwang-il
2011
Modelling the Atypical absorption of menatetrenone and the metabolism to its Epoxide: Effect of VKORC1 polymorphism.
Dr. Kwon Kwang-il
2011
Population pharmacokinetics of cyclosporine in korean adults undergoing living-donor kidney transplantation.
Dr. Kwon Kwang-il
2011
Simultaneous determination of l-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in the plasma of rodents with LC-MS/MS.
Dr. Kwon Kwang-il
2011
Pharmacokinetic characterization of decursinol derived from Angelica gigas Nakai in rats.
Dr. Kwon Kwang-il
2011
2011
Saponins from the roots of platycodon grandiflorum suppress ultraviolet a-induced matrix metalloproteinase-1 expression via MAPKs and NF- κ B/AP-1-dependent Signaling in HaCaT cells.
Dr. Kwon Kwang-il
2011
A study on platelet aggregation inhibitory effect of fermented.
Dr. Kwon Kwang-il
2011
A phase I study to characterize the multiple-dose pharmacokinetics, pharmacodynamics and safety of new Enteric-coated triflusal formulations in healthy male volunteers.
Dr. Kwon Kwang-il
2011
AMP-activated protein kinase (AMPK) activators from Myristica fragrans (nutmeg) and their anti-obesity effect.
Dr. Kwon Kwang-il
2010
Comparison of average, scaled average, and population bioequivalence methods for assessment of highly variable drugs: An experience with doxifluridine in beagle dogs.
Dr. Kwon Kwang-il
2010
Enantioselective pharmacokinetics of sibutramine in rat.
Dr. Kwon Kwang-il
2010
Quantitative determination of sparfloxacin in rat plasma by liquid Chromatography/ tandem mass spectrometry.
Dr. Kwon Kwang-il
2010
Biomarkers and surrogate outcome variables for efficient drug development of lung disease drugs.
Dr. Kwon Kwang-il
2010
Influence of dissolved oxygen concentration on the pharmacokinetics of alcohol in humans.
Dr. Kwon Kwang-il
2010
Melanin-Concentrating Hormone-1 receptor binding activity of pheophorbides isolated from morus alba leaves.
Dr. Kwon Kwang-il
2010
Evaluation of antioxidant defense systems in H4IIE cells infected with a retroviral vector.
Dr. Kwon Kwang-il
2010
Development and validation of a robust LC-MS/MS method for the simultaneous quantification of doxifluridine and its two metabolites in beagle dog plasma.
Dr. Kwon Kwang-il
2010
2010
3-Caffeoyl, 4-dihydrocaffeoylquinic acid from salicornia herbacea inhibits tumor cell invasion by regulating protein kinase C-δ-dependent matrix metalloproteinase-9 expression.
Dr. Kwon Kwang-il
2010
Preclinical pharmacokinetics of PDE-310, a novel PDE4 inhibitor.
Dr. Kwon Kwang-il
2010